Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CNBZ Stock Summary
In the News
CNBZ Financial details
Company Rating
Strong Buy
Market Cap
20.06M
Income
3.54M
Revenue
18.63M
Book val./share
-
Cash/share
-
Dividend
0.9
Dividend %
5.07%
Employees
79
Optionable
No
Shortable
Yes
Earnings
12 Nov 2021
P/E
-7.99
Forward P/E
-
PEG
17.46
P/S
2.17
P/B
1.19
P/C
-
P/FCF
12.79
Quick Ratio
-
Current Ratio
-
Debt / Equity
6.36
LT Debt / Equity
-
-
-
EPS (TTM)
2.92
EPS next Y
-
EPS next Q
1.57
EPS this Y
-4.58%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.07%
Revenue last 5Y
6.68%
Revenue Q/Q
-0.02%
EPS Q/Q
-22.22%
-
-
-
-
SMA20
-2.3%
SMA50
7.49%
SMA100
-10.86%
Inst Own
0%
Inst Trans
0%
ROA
-1%
ROE
-14%
ROC
-0.02%
Gross Margin
100%
Oper. Margin
-44%
Profit Margin
-27%
Payout
-
Shs Outstand
1.21M
Shs Float
1.2M
-
-
-
-
Target Price
-
52W Range
13.75-22.0
52W High
-24.77%
52W Low
+27.31%
RSI
19.93
Rel Volume
5.34
Avg Volume
191
Volume
1.02K
Perf Week
-12.89%
Perf Month
-12.89%
Perf Quarter
-
Perf Half Y
-19.07%
-
-
-
-
Beta
-0.189
-
-
Volatility
1.16%, 0.8%
Prev Close
0.36%
Price
16.55
Change
-5.43%
CNBZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.1 | 13.24 | 13.25 | 13.89 | 0 | |
Net income per share | 1.58 | 2.32 | 2.48 | 3.06 | 0 | |
Operating cash flow per share | 2.04 | 1.98 | 2.95 | 3.32 | 0 | |
Free cash flow per share | 1.52 | 1.65 | 1.02 | 3.14 | 0 | |
Cash per share | 20.43 | 37.08 | 18.08 | 9.02 | 0 | |
Book value per share | 22.48 | 25.33 | 24.07 | 2.19 | 0 | |
Tangible book value per share | 21.77 | 24.32 | 22.82 | 1.06 | 0 | |
Share holders equity per share | 22.48 | 25.33 | 24.07 | 2.19 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 27.24M | 23.1M | 27.06M | 24.21M | 0 | |
Enterprise value | 2.5M | -21.79M | 5.17M | 13.29M | 63.97M | |
P/E ratio | 14.22 | 8.21 | 9.01 | 6.53 | 0 | |
Price to sales ratio | 2.03 | 1.44 | 1.69 | 1.44 | 0 | |
POCF ratio | 11.02 | 9.63 | 7.58 | 6.02 | 0 | |
PFCF ratio | 14.76 | 11.56 | 21.86 | 6.37 | 0 | |
P/B Ratio | 1 | 0.75 | 0.93 | 9.11 | 0 | |
PTB ratio | 1 | 0.75 | 0.93 | 9.11 | 0 | |
EV to sales | 0.19 | -1.36 | 0.32 | 0.79 | 3.44 | |
Enterprise value over EBITDA | 1.09 | -6.36 | 1.41 | 2.91 | 0 | |
EV to operating cash flow | 1.01 | -9.09 | 1.45 | 3.3 | 0 | |
EV to free cash flow | 1.36 | -10.91 | 4.17 | 3.5 | 0 | |
Earnings yield | 0.07 | 0.12 | 0.11 | 0.15 | 0 | |
Free cash flow yield | 0.07 | 0.09 | 0.05 | 0.16 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 6.36 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.12 | |
Net debt to EBITDA | -10.8 | -13.1 | -5.97 | -2.39 | 0 | |
Current ratio | 0.27 | 0.29 | 0.13 | 0.07 | 0.09 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.29 | 0.85 | 1.19 | 1.08 | 0 | |
Dividend Yield | 0.04 | 0.04 | 0.04 | 0.05 | 0 | |
Payout ratio | 0.51 | 0.34 | 0.36 | 0.29 | 0 | |
Sales general and administrative to revenue | 0.13 | 0.11 | 0.12 | 0.11 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.25 | -0.17 | -0.65 | -0.06 | 0 | |
Capex to revenue | -0.05 | -0.02 | -0.15 | -0.01 | 0 | |
Capex to depreciation | -1.02 | -0.84 | -4.82 | -0.5 | 0 | |
Stock based compensation to revenue | 0 | 0 | -0.06 | -0.05 | 0 | |
Graham number | 28.29 | 36.38 | 36.66 | 12.3 | 0 | |
ROIC | 0.05 | 0.08 | 0.09 | 1.26 | 0.18 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -214.54 | -267.84 | -364.56 | -388.82 | 0 | |
Working capital | -110.75M | -137.55M | -213.98M | -259.85M | -189.87M | |
Tangible asset value | 26.36M | 29.44M | 27.63M | 1.28M | 8.96M | |
Net current asset value | -243.2M | -311.65M | -431.58M | -462.61M | -458.64M | |
Invested capital | 0 | 0 | 0 | 0 | 6.36 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.07 | 0.09 | 0.1 | 1.4 | 0.39 | |
Capex per share | -0.52 | -0.33 | -1.92 | -0.18 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.78 | 3.6 | 3.72 | 4.03 | 0 | |
Net income per share | 1.08 | 0.57 | 0.75 | 0.9 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | -6.75 | 16.9 | 16.9 | -8.1 | 0 | |
Book value per share | 2.19 | 2.1 | 4.39 | -0.77 | 0 | |
Tangible book value per share | 2.19 | 2.1 | 4.39 | -0.77 | 0 | |
Share holders equity per share | 2.19 | 2.1 | 4.39 | -0.77 | 0 | |
Interest debt per share | 0 | 0 | 23.95 | 23.95 | 0 | |
Market cap | 24.21M | 24.82M | 23M | 24.76M | 0 | |
Enterprise value | 32.39M | 4.35M | 31.54M | 63.56M | 63.97M | |
P/E ratio | 4.64 | 8.98 | 6.35 | 5.69 | 0 | |
Price to sales ratio | 5.29 | 5.69 | 5.11 | 5.07 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 9.11 | 9.77 | 4.33 | -26.65 | 0 | |
PTB ratio | 9.11 | 9.77 | 4.33 | -26.65 | 0 | |
EV to sales | 7.08 | 1 | 7.01 | 13.02 | 13.1 | |
Enterprise value over EBITDA | 0 | 4.44 | 32.2 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.05 | 0.03 | 0.04 | 0.04 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 5.45 | -31.22 | 6.36 | |
Debt to assets | 0 | 0 | 0.06 | 0.06 | 0.12 | |
Net debt to EBITDA | 0 | -20.9 | 8.71 | 0 | 0 | |
Current ratio | 0.07 | 0.1 | 0.14 | 0.19 | 0.09 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.88 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.3 | 5.19 | 8.6 | 3.94 | 0 | |
ROIC | 1.12 | 0.32 | 0.02 | 0.11 | 0.05 | |
Return on tangible assets | 0.02 | 0 | 0 | 0 | 0 | |
Graham Net | -404.6 | -377.93 | -384.05 | -419.33 | 0 | |
Working capital | -259.85M | -142.93M | -163.69M | -160.7M | -189.87M | |
Tangible asset value | -423.75M | 2.54M | 5.32M | -929K | 8.96M | |
Net current asset value | -462.61M | -462.87M | -457.82M | -460M | -458.64M | |
Invested capital | 0 | 0 | 5.45 | -31.22 | 6.36 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.49 | 0.27 | 0.17 | -1.17 | 0.1 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CNBZ Frequently Asked Questions
What is CNB Corporation stock symbol ?
CNB Corporation is a US stock , located in Cheboygan of Mi and trading under the symbol CNBZ
What is CNB Corporation stock quote today ?
CNB Corporation stock price is $16.55 today.
Is CNB Corporation stock public?
Yes, CNB Corporation is a publicly traded company.